Off-label use of biologics for the treatment of refractory and/or relapsing granulomatosis with polyangiitis.
Sign Up to like & getrecommendations! Published in 2021 at "European journal of internal medicine"
DOI: 10.1016/j.ejim.2021.10.028
Abstract: OBJECTIVE To describe the efficacy and safety of off-label use of biologics for refractory and/or relapsing granulomatosis with polyangiitis (GPA). METHODS We conducted a French retrospective study including GPA patients who received off-label biologics for… read more here.
Keywords: treatment; refractory relapsing; label use; use biologics ... See more keywords